Studying the effect of vitamin D administration on the response to Helicobacter pylori treatment in children and adolescents. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Definitive diagnosis of Helicobacter pylori infection based on endoscopy and gastric biopsy results along with Giemsa staining Children and adolescents between the ages of 5 and 18 years
Exclusion criteria
Exclusion criteria: Abnormal or very low/very high serum vitamin D levels at baseline Taking vitamin D supplements or medications containing it within the past three months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success in eradicating H. pylori infection. Timepoint: 4 weeks after stopping treatment. Method of measurement: Fecal antigen test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum vitamin D level. Timepoint: After 4 weeks of complete cessation of treatment (simultaneous with eradication testing). Method of measurement: Blood sampling and measurement of serum vitamin D levels. | — |
Countries
Iran (Islamic Republic of)
Contacts
Hamedan University of Medical Sciences